Richard Murray

Richard Murray is the founder of Jounce Therapeutics. Jounce Therapeutics has raised $103M in total funding. Latest round: Series B.

About Richard Murray

Dr. Richard Murray is the CEO of Jounce Therapeutics, a Cambridge, Massachusetts-based biotech company focused on cancer immunotherapies. He joined Jounce in 2024 and previously served as an executive at Merck & Co. Murray has overseen significant funding milestones, including a $56 million Series B round for the company.

Richard Murray at a glance

More founders in Cambridge, Massachusetts, United States (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library